Ligand profile
13I
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_32123 — chaperone protein HtpG
Identifiers
Database identifiers and provenance.
- Ligand ID
13I- PDB
2xx4- UniProt (similar protein)
P02829- Target protein
- KP13_32123
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 116.1
- −1 ≤ LogP ≤ 5 2.69
- MW ≤ 500 Da 411.9
- LogP ≤ 5 2.69
- H-bond donors ≤ 5 4
- H-bond acceptors ≤ 10 6
- Rotatable bonds ≤ 10 3
- TPSA ≤ 140 Ų 116.1
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CCO[C@H]([C@H]1CCC\C=C\CCNC(=O)c2c(cc(c(c2CC1=O)Cl)O)O)OCCO[C@H]([C@H]1CCC\C=C\CCNC(=O)c2c(cc(c(c2CC1=O)Cl)O)O)O
InChI=1S/C20H26ClNO6/c1-2-28-20(27)12-8-6-4-3-5-7-9-22-19(26)17-13(10-14(12)23)18(21)16(25)11-15(17)24/h3,5,11-12,20,24-25,27H,2,4,6-10H2,1H3,(H,22,26)/b5-3+/t12-,20+/m0/s1InChI=1S/C20H26ClNO6/c1-2-28-20(27)12-8-6-4-3-5-7-9-22-19(26)17-13(10-14(12)23)18(21)16(25)11-15(17)24/h3,5,11-12,20,24-25,27H,2,4,6-10H2,1H3,(H,22,26)/b5-3+/t12-,20+/m0/s1
YLRTXPICDJPGMD-CVRKFZKPSA-NYLRTXPICDJPGMD-CVRKFZKPSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF02518
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand 13I →
- PDB RCSB structure 2xx4 →
- UniProt UniProt P02829 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “13I”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_32123.
PDB 27
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 6
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).